Zeigler signed a NIL deal with Spyre Sports Group which is a sports marketing and media agency based in Tennessee. A. Zakai Zeigler has inked deals with The Dairy Alliance, The Players' Lounge ...

WALTHAM, Mass., March 7, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing ...

WALTHAM, Mass., March 7, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, ...

Spyre Therapeutics is emerging as a key player in inflammatory bowel disease, with a focus on pathway-specific monoclonal antibodies for superior disease control. The company has a healthy balance ...

JonesTrading analyst Debanjana Chatterjee reiterated a Hold rating on Spyre Therapeutics (SYRE – Research Report) today. The company’s shares closed last Friday at $19.70. See what stocks are ...

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report)’s stock price rose 6.6% during trading on Friday after the company announced better than expected quarterly earnings. The company ...

Google Maps is one of the most useful navigational tools on Android. It enables people to preview a trip and plan for obstacles. However, knowing how to find where you are right now on the map is ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it ...